GO
Loading...

Novartis CEO: Our Innovation Will Be Rewarded

Wednesday, 23 Jan 2013 | 2:10 AM ET

Joe Jimenez, CEO of Novartis, tells CNBC that 2012 was a transition year for Novartis with 17 major drug approvals.